Clinical Trial Update: Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone [Phase 2]

View source ↗

Summary

This Phase 2 trial update notes that the study evaluating pioglitazone as an adjunct to early MIPS surgery for intracerebral and intraventricular hemorrhage has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage
• Intraventricular Hemorrhage

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Intracerebral Haemorrhage, Intraventricular | Phase 2 | Status: TERMINATED